Live Nasdaq Composite: Markets Poised to Lock in Weekly Gains Amid AI Earnings-Powered Cycle

Investing

GSK : GSK

All GSK Articles

257 Articles

Lee Jackson | Sep 9, 2022 at 8:49 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: Chipotle, CrowdStrike, First Solar, GSK, Intel, Nvidia, Starbucks and More

Friday's top analyst upgrades and downgrades included Chipotle Mexican Grill, CrowdStrike, First Solar, Fortinet, Franklin Resources, GSK, Intel, Nvidia, Shoals…

Lee Jackson | Jul 22, 2022 at 8:47 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: Alcoa, Blue Apron, Enterprise Products Partners, GSK, Nordstrom, Southwestern Energy, Tesla and More

Friday's top analyst upgrades and downgrades included Alcoa, Blue Apron, Brixmor Property, Enterprise Products Partners, FIGS, GSK, Healthcare Realty Trust,…

Lee Jackson | Feb 14, 2022 at 8:52 AM EST

Monday’s Top Analyst Upgrades and Downgrades: Chewy, Coca-Cola, GlaxoSmithKline, Micron Technology, SoFi, Teladoc, Twitter, Walmart and More

Monday's top analyst upgrades and downgrades included Chewy, Cloudflare, Coca-Cola, Doximity, Ideanomics, GlaxoSmithKline, Micron Technology, SoFi Technologies, Teladoc Health, Twitter…

Chris Lange | Nov 5, 2021 at 11:50 AM EDT

Friday Afternoon Analyst Upgrades and Downgrades: GlaxoSmithKline, Nikola, Shake Shack and More

Friday afternoon's analyst upgrades and downgrades included BigCommerce, Citrix, GlaxoSmithKline, Nikola, Regeneron, Shake Shack and more.

Chris Lange | Jun 24, 2021 at 9:03 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Analog Devices, Activision Blizzard, BP, Clorox, EA, MGM PayPal, Square, and More

Thursday’s top analyst upgrades and downgrades included Analog Devices, Activision Blizzard, BP, Clorox, EA, MGM PayPal, Square and more.

Chris Lange | Mar 23, 2021 at 11:48 AM EDT

DraftKings, GlaxoSmithKline, Netflix, Southwest and More Tuesday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Alexion, DraftKings,…

Lee Jackson | Feb 4, 2021 at 8:59 AM EST

Top Analyst Upgrades and Downgrades: Apple, Best Buy, Electronic Arts, FireEye, Match, PayPal, Qualcomm, ViacomCBS and More

Thursday's top analyst upgrades and downgrades included Apple, Best Buy, Electronic Arts, FireEye, Match, PayPal, Qualcomm and ViacomCBS.

Lee Jackson | Jan 20, 2021 at 8:41 AM EST

Top Analyst Upgrades and Downgrades: Altria, Boeing, Coca-Cola, GlaxoSmithKline, Halliburton, Kroger, Netflix and More

Wednesday's top analyst upgrades and downgrades included Altria, Boeing, Coca-Cola, GlaxoSmithKline, Halliburton, Kroger, Netflix and Pioneer Natural Resources.

Chris Lange | Oct 6, 2020 at 10:00 AM EDT

Vir Biotechnology Expands Its Late-Stage COVID-19 Study

Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in…

Jon C. Ogg | Oct 5, 2020 at 1:28 PM EDT

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that…

Chris Lange | Oct 5, 2020 at 11:12 AM EDT

How Nvidia Is Fighting Disease With AI

Nvidia has announced it will partner with GlaxoSmithKline to apply its artificial intelligence and supercomputers for the drug and vaccine…

Chris Lange | Jul 20, 2020 at 10:21 AM EDT

GlaxoSmithKline Joins the Race for a COVID-19 Vaccine

GlaxoSmithKline has announced that it is acquiring a 10% stake in the German biopharma firm CureVac.

Chris Lange | May 13, 2020 at 1:48 PM EDT

Huge Sales Growth Brightens Future for Amarin Stock

There are still a lot of questions for Amarin must figure out before it gets back on track. For investors,…

Chris Lange | Apr 17, 2020 at 7:30 AM EDT

Is Amarin Stock Doomed After Court Ruling?

Amarin stock was absolutely crushed at the tail end of March, and now the company is dealing with the fallout.…

Douglas A. McIntyre | Mar 31, 2020 at 12:29 PM EDT

Co-Diagnostics Stock Is Not a Penny Stock Anymore

Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on…

1 2 3 4 … 18

GSK : GSK

All GSK Articles

Friday’s Top Analyst Upgrades and Downgrades: Chipotle, CrowdStrike, First Solar, GSK, Intel, Nvidia, Starbucks and More

Friday’s Top Analyst Upgrades and Downgrades: Alcoa, Blue Apron, Enterprise Products Partners, GSK, Nordstrom, Southwestern Energy, Tesla and More

Monday’s Top Analyst Upgrades and Downgrades: Chewy, Coca-Cola, GlaxoSmithKline, Micron Technology, SoFi, Teladoc, Twitter, Walmart and More

Friday Afternoon Analyst Upgrades and Downgrades: GlaxoSmithKline, Nikola, Shake Shack and More

Thursday’s Top Analyst Upgrades and Downgrades: Analog Devices, Activision Blizzard, BP, Clorox, EA, MGM PayPal, Square, and More

DraftKings, GlaxoSmithKline, Netflix, Southwest and More Tuesday Afternoon Analyst Calls

Top Analyst Upgrades and Downgrades: Apple, Best Buy, Electronic Arts, FireEye, Match, PayPal, Qualcomm, ViacomCBS and More

Top Analyst Upgrades and Downgrades: Altria, Boeing, Coca-Cola, GlaxoSmithKline, Halliburton, Kroger, Netflix and More

Vir Biotechnology Expands Its Late-Stage COVID-19 Study

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

How Nvidia Is Fighting Disease With AI

GlaxoSmithKline Joins the Race for a COVID-19 Vaccine

Huge Sales Growth Brightens Future for Amarin Stock

Is Amarin Stock Doomed After Court Ruling?

Co-Diagnostics Stock Is Not a Penny Stock Anymore

Live Nasdaq Composite: Markets Poised to Lock in Weekly Gains Amid AI Earnings-Powered Cycle

The Gold “Income” Fund That Turned a 6% Gold Dip Into a 30% Loss

Michael Burry Ramped Up His Bets Against Micron and the QQQ ETF. Is the ‘Big Short’ Investor Asking for Trouble?

SoundHound Shed a Quarter of Its Value Over 12 Months: 167% Gains To Follow Says A Prominent Analyst

56% of Workers Plan to Retire at 65 or Later. The Average American Is Out at 62, and Not by Choice.

Her Husband Delayed Social Security to 70 for a Bigger Check. Her Spousal Benefit Never Grew With It.

The Gold “Income” Fund That Turned a 6% Gold Dip Into a 30% Loss

Michael Burry Ramped Up His Bets Against Micron and the QQQ ETF. Is the ‘Big Short’ Investor Asking for Trouble?

GSK : GSK

All GSK Articles

Friday’s Top Analyst Upgrades and Downgrades: Chipotle, CrowdStrike, First Solar, GSK, Intel, Nvidia, Starbucks and More

Friday’s Top Analyst Upgrades and Downgrades: Alcoa, Blue Apron, Enterprise Products Partners, GSK, Nordstrom, Southwestern Energy, Tesla and More

Monday’s Top Analyst Upgrades and Downgrades: Chewy, Coca-Cola, GlaxoSmithKline, Micron Technology, SoFi, Teladoc, Twitter, Walmart and More

Friday Afternoon Analyst Upgrades and Downgrades: GlaxoSmithKline, Nikola, Shake Shack and More

Thursday’s Top Analyst Upgrades and Downgrades: Analog Devices, Activision Blizzard, BP, Clorox, EA, MGM PayPal, Square, and More

DraftKings, GlaxoSmithKline, Netflix, Southwest and More Tuesday Afternoon Analyst Calls

Top Analyst Upgrades and Downgrades: Apple, Best Buy, Electronic Arts, FireEye, Match, PayPal, Qualcomm, ViacomCBS and More

Top Analyst Upgrades and Downgrades: Altria, Boeing, Coca-Cola, GlaxoSmithKline, Halliburton, Kroger, Netflix and More

Vir Biotechnology Expands Its Late-Stage COVID-19 Study

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

How Nvidia Is Fighting Disease With AI

GlaxoSmithKline Joins the Race for a COVID-19 Vaccine

Huge Sales Growth Brightens Future for Amarin Stock

Is Amarin Stock Doomed After Court Ruling?

Co-Diagnostics Stock Is Not a Penny Stock Anymore

Live Nasdaq Composite: Markets Poised to Lock in Weekly Gains Amid AI Earnings-Powered Cycle

The Gold “Income” Fund That Turned a 6% Gold Dip Into a 30% Loss

Michael Burry Ramped Up His Bets Against Micron and the QQQ ETF. Is the ‘Big Short’ Investor Asking for Trouble?

SoundHound Shed a Quarter of Its Value Over 12 Months: 167% Gains To Follow Says A Prominent Analyst

Featured Reads

56% of Workers Plan to Retire at 65 or Later. The Average American Is Out at 62, and Not by Choice.

Her Husband Delayed Social Security to 70 for a Bigger Check. Her Spousal Benefit Never Grew With It.